Do Current Valuations Warrant A Buy or Sell? – Xeris Pharmaceuticals, Inc. (XERS), American International Group, Inc. (AIG) – Post Analyst

This post was originally published on this site

Do Current Valuations Warrant A Buy or Sell? – Xeris Pharmaceuticals, Inc. (XERS), American International Group, Inc. (AIG)  Post Analyst

Here’s what’s interesting to note about Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) right now: Its price-to-sales ratio of 137.45, is expensive relative to the …

This post was originally published on *this site*